COLUMBUS- Hy-Vee has announced all Hy-Vee Pharmacy locations across its eight-state region now offer test-to-treat COVID-19 services using the COVID-19 antiviral, PAXLOVID, to help treat mild-to-moderate cases of COVID-19 in certain patients who are at high risk for progression to severe COVID-19. 

Earlier this month, the FDA authorized state-licensed pharmacists to prescribe PAXLOVID to eligible patients ages 12+, with certain limitations. In order to be prescribed PAXLOVID, patients must test positive for COVID-19. After receiving a positive COVID-19 test result, patients will be screened by a state-licensed Hy-Vee pharmacist to determine their eligibility for PAXLOVID.

It is recommended that patients begin COVID-19 antiviral treatment as soon as possible, and treatment must begin within five days of when symptoms begin.